{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:27:54Z","timestamp":1791908874002,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Surface Project of Nantong Municipal Health Commission","award":["No. MS2023105"],"award-info":[{"award-number":["No. MS2023105"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14059-2","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T06:13:09Z","timestamp":1744611189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["EXOSC5: a novel biomarker for poor prognosis in lung adenocarcinoma"],"prefix":"10.1186","volume":"25","author":[{"given":"Jianxun","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengmei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"issue":"6","key":"14059_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA-CANCER J CLIN. 2018;68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA-CANCER J CLIN"},{"issue":"2","key":"14059_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA-CANCER J CLIN. 2016;66(2):115\u201332. https:\/\/doi.org\/10.3322\/caac.21338.","journal-title":"CA-CANCER J CLIN"},{"issue":"1","key":"14059_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA-CANCER J CLIN. 2018;68(1):7\u201330. https:\/\/doi.org\/10.3322\/caac.21442.","journal-title":"CA-CANCER J CLIN"},{"key":"14059_CR4","doi-asserted-by":"crossref","unstructured":"Heist RS, Engelman JA. SnapShot: non-small cell lung cancer. Cancer Cell. 2012;21(3). 448.e2.","DOI":"10.1016\/j.ccr.2012.03.007"},{"issue":"4","key":"14059_CR5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/s0092-8674(01)00578-5","volume":"107","author":"CY Chen","year":"2001","unstructured":"Chen CY, Gherzi R, Ong SE, Chan EL, Raijmakers R, Pruijn GJ, et al. AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell. 2001;107(4):451\u201364. https:\/\/doi.org\/10.1016\/s0092-8674(01)00578-5.","journal-title":"Cell"},{"issue":"2","key":"14059_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1261\/rna.064626.117","volume":"24","author":"DJ Morton","year":"2017","unstructured":"Morton DJ, Kuiper EG, Jones SK, Leung SW, Corbett AH, Fasken MB. The RNA exosome and RNA exosome-linked disease. RNA. 2017;24(2):127\u201342. https:\/\/doi.org\/10.1261\/rna.064626.117.","journal-title":"RNA"},{"key":"14059_CR7","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1038\/ncomms5287","volume":"5","author":"V Boczonadi","year":"2014","unstructured":"Boczonadi V, M\u00fcller JS, Pyle A, Munkley J, Dor T, Quartararo J, et al. EXOSC8 mutations alter mRNA metabolism and cause hypomyelination with spinal muscular atrophy and cerebellar hypoplasia. Nat Commun. 2014;5:4287. https:\/\/doi.org\/10.1038\/ncomms5287.","journal-title":"Nat Commun"},{"issue":"6","key":"14059_CR8","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1136\/jmedgenet-2015-103511","volume":"53","author":"N Di Donato","year":"2016","unstructured":"Di Donato N, Neuhann T, Kahlert AK, Klink B, Hackmann K, Neuhann I, et al. Mutations in EXOSC2 are associated with a novel syndrome characterized by retinitis pigmentosa, progressive hearing loss, premature ageing, short stature, mild intellectual disability and distinctive gestalt. J MED GENET. 2016;53(6):419\u201325. https:\/\/doi.org\/10.1136\/jmedgenet-2015-103511.","journal-title":"J MED GENET"},{"issue":"6","key":"14059_CR9","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/ng.2254","volume":"44","author":"J Wan","year":"2012","unstructured":"Wan J, Yourshaw M, Mamsa H, Rudnik-Sch\u00f6neborn S, Menezes MP, Hong JE, et al. Mutations in the RNA exosome component gene EXOSC3 cause pontocerebellar hypoplasia and spinal motor neuron degeneration. NAT GENET. 2012;44(6):704\u20138. https:\/\/doi.org\/10.1038\/ng.2254.","journal-title":"NAT GENET"},{"issue":"1","key":"14059_CR10","doi-asserted-by":"publisher","first-page":"9275","DOI":"10.1038\/s41598-020-66455-2","volume":"10","author":"S Yoshino","year":"2020","unstructured":"Yoshino S, Matsui Y, Fukui Y, Seki M, Yamaguchi K, Kanamori A, et al. EXOSC9 depletion attenuates P-body formation, stress resistance, and tumorigenicity of cancer cells. Sci Rep. 2020;10(1):9275. https:\/\/doi.org\/10.1038\/s41598-020-66455-2.","journal-title":"Sci Rep"},{"key":"14059_CR11","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3389\/fonc.2019.00643","volume":"9","author":"H Pan","year":"2019","unstructured":"Pan H, Pan J, Song S, Ji L, Lv H, Yang Z. EXOSC5 as a novel prognostic marker promotes proliferation of colorectal cancer via activating the ERK and AKT pathways. Front Oncol. 2019;9:643. https:\/\/doi.org\/10.3389\/fonc.2019.00643.","journal-title":"Front Oncol"},{"key":"14059_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. BMC Bioinformatics. 2013;14:7. https:\/\/doi.org\/10.1186\/1471-2105-14-7. GSVA: gene set variation analysis for microarray and RNA-seq data."},{"issue":"4","key":"14059_CR13","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39(4):782\u201395. https:\/\/doi.org\/10.1016\/j.immuni.2013.10.003.","journal-title":"Immunity"},{"issue":"9","key":"14059_CR14","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s12032-014-0154-x","volume":"31","author":"M Inomata","year":"2014","unstructured":"Inomata M, Hayashi R, Tokui K, Taka C, Okazawa S, Kambara K, et al. Usefulness of the palliative prognostic index in patients with lung cancer. MED ONCOL. 2014;31(9):154. https:\/\/doi.org\/10.1007\/s12032-014-0154-x.","journal-title":"MED ONCOL"},{"issue":"4","key":"14059_CR15","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3322\/caac.21765","volume":"73","author":"V Davalos","year":"2022","unstructured":"Davalos V, Esteller M. Cancer epigenetics in clinical practice. CA-CANCER J CLIN. 2022;73(4):376\u2013424. https:\/\/doi.org\/10.3322\/caac.21765.","journal-title":"CA-CANCER J CLIN"},{"issue":"7","key":"14059_CR16","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41568-021-00358-w","volume":"21","author":"PK Kopinski","year":"2021","unstructured":"Kopinski PK, Singh LN, Zhang S, et al. Mitochondrial DNA variation and cancer. NAT REV CANCER. 2021;21(7):431\u201345. https:\/\/doi.org\/10.1038\/s41568-021-00358-w.","journal-title":"NAT REV CANCER"},{"issue":"29","key":"14059_CR17","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1200\/JCO.2018.79.3299","volume":"36","author":"DKM De Ruysscher","year":"2018","unstructured":"De Ruysscher DKM, Decaluw\u00e9 H. 4 L lymph node involvement in Left-Sided lung cancer: unique or not?? J CLIN ONCOL. 2018;36(29):2907\u20138. https:\/\/doi.org\/10.1200\/JCO.2018.79.3299.","journal-title":"J CLIN ONCOL"},{"issue":"8","key":"14059_CR18","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1097\/JTO.0b013e31812f3c1a","volume":"2","author":"P Goldstraw","year":"2007","unstructured":"Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, et al. The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J THORAC ONCOL. 2007;2(8):706\u201314.","journal-title":"J THORAC ONCOL"},{"issue":"5","key":"14059_CR19","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.3892\/or.2020.7524","volume":"43","author":"Z Zheng","year":"2020","unstructured":"Zheng Z, Mao S, Guo Y, Zhang W, Liu J, Li C, et al. N6methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma. ONCOL REP. 2020;43(5):1591\u2013605. https:\/\/doi.org\/10.3892\/or.2020.7524.","journal-title":"ONCOL REP"},{"issue":"4","key":"14059_CR20","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/s1097-2765(03)00095-9","volume":"11","author":"JZ Parrish","year":"2003","unstructured":"Parrish JZ, Xue D. Functional genomic analysis of apoptotic DNA degradation in C. elegans. MOL CELL. 2003;11(4):987\u201396. https:\/\/doi.org\/10.1016\/s1097-2765(03)00095-9.","journal-title":"MOL CELL"},{"issue":"9","key":"14059_CR21","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1261\/rna.2180810","volume":"16","author":"CC Yang","year":"2010","unstructured":"Yang CC, Wang YT, Hsiao YY, Doudeva LG, Kuo PH, Chow SY, et al. Structural and biochemical characterization of CRN-5 and Rrp46: an exosome component participating in apoptotic DNA degradation. RNA. 2010;16(9):1748\u201359. https:\/\/doi.org\/10.1261\/rna.2180810.","journal-title":"RNA"},{"issue":"3","key":"14059_CR22","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/pros.1066","volume":"47","author":"DG McNeel","year":"2001","unstructured":"McNeel DG, Nguyen LD, Ellis WJ, Higano CS, Lange PH, Disis ML. Naturally occurring prostate cancer antigen-specific T-cell responses of a Th1 phenotype can be detected in patients with prostate cancer. Prostate. 2001;47(3):222\u20139. https:\/\/doi.org\/10.1002\/pros.1066.","journal-title":"Prostate"},{"key":"14059_CR23","doi-asserted-by":"crossref","unstructured":"McNeel DG., Nguyen LD., Storer BE., Vessella R., Lange PH., Disis ML. Antibody immunity to prostate cancer associated antigens can be detected in the serum of patients with prostate cancer. J Urol. 2000;164(5):1825\u20139. PMID: 11025777.","DOI":"10.1016\/S0022-5347(05)67114-5"},{"issue":"19","key":"14059_CR24","first-page":"5517","volume":"62","author":"XF Yang","year":"2002","unstructured":"Yang XF, Wu CJ, Chen L, Alyea EP, Canning C, Kantoff P, et al. CML28 is a broadly Immunogenic antigen, which is overexpressed in tumor cells. CANCER RES. 2002;62(19):5517\u201322. PMID: 12359762.","journal-title":"CANCER RES"},{"issue":"1","key":"14059_CR25","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.bbrc.2006.06.093","volume":"347","author":"H Zhou","year":"2006","unstructured":"Zhou H, Zhang D, Wang Y, Dai M, Zhang L, Liu W, et al. Induction of CML28-specific cytotoxic T-cell responses using cotransfected dendritic cells with CML28 DNA vaccine and SOCS1 small interfering RNA expression vector. BIOCHEM BIOPH RES CO. 2006;347(1):200\u20137. https:\/\/doi.org\/10.1016\/j.bbrc.2006.06.093.","journal-title":"BIOCHEM BIOPH RES CO"},{"issue":"9","key":"14059_CR26","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1097\/CJI.0b013e31827806e6","volume":"35","author":"CA Klebanoff","year":"2012","unstructured":"Klebanoff CA, Gattinoni L, Restifo NP. Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy? J IMMUNOTHER. 2012;35(9):651\u201360. https:\/\/doi.org\/10.1097\/CJI.0b013e31827806e6.","journal-title":"J IMMUNOTHER"},{"issue":"27","key":"14059_CR27","doi-asserted-by":"publisher","first-page":"9571","DOI":"10.1073\/pnas.0503726102","volume":"102","author":"CA Klebanoff","year":"2005","unstructured":"Klebanoff CA, Gattinoni L, Torabi-Parizi P, Kerstann K, Cardones AR, Finkelstein SE, et al. Central memory self\/tumor-reactive CD8\u2009+\u2009T cells confer superior antitumour immunity compared with effector memory T cells. P NATL ACAD SCI USA. 2005;102(27):9571\u20136.","journal-title":"P NATL ACAD SCI USA"},{"issue":"3suppl","key":"14059_CR28","doi-asserted-by":"publisher","first-page":"TPS454","DOI":"10.1200\/jco.2021.39.3_suppl.tps454","volume":"39","author":"I Pellicciotta","year":"2021","unstructured":"Pellicciotta I, Alouani E, Raufi A, Pan S, Hu J, Manji G. Chemo4MetPanc: A phase II study with combination chemotherapy (gemcitabine and nab-paclitaxel), chemokine (C-X-C) motif receptor 4 inhibitor (motixafortide), and immune checkpoint Blockade (cemiplimab) in metastatic treatment Na\u00efve pancreas adenocarcinoma (PDAC). J CLIN ONCOL. 2021;39(3suppl):TPS454\u2013454. https:\/\/doi.org\/10.1200\/jco.2021.39.3_suppl.tps454.","journal-title":"J CLIN ONCOL"},{"issue":"5","key":"14059_CR29","doi-asserted-by":"publisher","first-page":"837","DOI":"10.15789\/1563-0625-ivm-1975","volume":"22","author":"E Blinova","year":"2020","unstructured":"Blinova E, Kolerova A, Balyasnikov V, Kozlov V. In vitro maintaining of CD4 central and effector memory cells in normal and inflammatory conditions. Meditsinskaia Immunol. 2020;22(5):837\u201346. https:\/\/doi.org\/10.15789\/1563-0625-ivm-1975.","journal-title":"Meditsinskaia Immunol"},{"issue":"1","key":"14059_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cyto.2015.05.010","volume":"75","author":"J Zhu","year":"2015","unstructured":"Zhu J. T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production. Cytokine. 2015;75(1):14\u201324. https:\/\/doi.org\/10.1016\/j.cyto.2015.05.010.","journal-title":"Cytokine"},{"key":"14059_CR31","doi-asserted-by":"publisher","unstructured":"Murray PJ. Macrophage polarization. ANNU REV PHYSIOL. 2016;79:541\u201366. https:\/\/doi.org\/10.1146\/annurev-physiol-022516-034339.","DOI":"10.1146\/annurev-physiol-022516-034339"},{"issue":"17","key":"14059_CR32","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.21037\/atm-20-4437","volume":"8","author":"MJ Li","year":"2020","unstructured":"Li MJ, Wang X, Chen Y, Li GJ, Zhao GQ, Xiang BQ, Wei XQ, Lei YJ, Huang YC. The influences of TGF-\u03b21 upon the human adenocarcinoma cell of lung A549 and cellular immunity. ANN TRANSL MED. 2020;8(17):1076. https:\/\/doi.org\/10.21037\/atm-20-4437.","journal-title":"ANN TRANSL MED"},{"issue":"1","key":"14059_CR33","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s12964-022-00872-w","volume":"21","author":"Y Lu","year":"2023","unstructured":"Lu Y, Han G, Zhang Y, Zhang L, Li Z, Wang Q, Chen Z, Wang X, Wu J. M2 macrophage-secreted exosomes promote metastasis and increase vascular permeability in hepatocellular carcinoma. Cell Commun Signal. 2023;21(1):299. https:\/\/doi.org\/10.1186\/s12964-022-00872-w.","journal-title":"Cell Commun Signal"},{"issue":"7637","key":"14059_CR34","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","volume":"541","author":"DS Chen","year":"2017","unstructured":"Chen DS, Mellman I. Elements of cancer immunity and the cancer\u2013immune set point. Nature. 2017;541(7637):321\u201330. https:\/\/doi.org\/10.1038\/nature21349.","journal-title":"Nature"},{"issue":"4","key":"14059_CR35","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nri3175","volume":"12","author":"DI Gabrilovich","year":"2012","unstructured":"Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol. 2012;12(4):253\u201368. https:\/\/doi.org\/10.1038\/nri3175.","journal-title":"Nat Rev Immunol"},{"key":"14059_CR36","doi-asserted-by":"publisher","unstructured":"Yu JC, Lin G, Field JJ, Linden J. Induction of antiinflammatory purinergic signaling in activated human iNKT cells. JCI Insight. 2018;3(17). https:\/\/doi.org\/10.1172\/jci.insight.91954.","DOI":"10.1172\/jci.insight.91954"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14059-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14059-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14059-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T06:13:11Z","timestamp":1744611191000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14059-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14059"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14059-2","relation":{"references":[{"id-type":"doi","id":"10.1186\/1471-2105-14-7","asserted-by":"subject"}],"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5782899\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"assertion":[{"value":"7 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was officially recognized for it strictly carried out the procedures for care and use admitted by the Ethics Committee of the Affiliated Hospital of Nantong University (Ethic Number: 2018-K020). Written informed consents were obtained from all participants. We confirmed that experiments on humans and\/or the use of human tissue samples were performed in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Manuscript is approved by all authors for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"681"}}